evitria company logo
    • Recombinant Ab Production Service
    • Afucosylated Ab Service
    • Fc-silenced Ab Service
    • Bispecific Ab Production Service
    • HTP Production Service
    • Other Protein Production Service
  • Products
    • STR – True Fc Silencing Technology
    • GlymaxX® – Glycoengineering and ADCC Enhancement
    • Opti-mAb® – scFv Stabilization
    Our Technologies
    • About Evitria
    • Events
    • Partnerships
    • FAQs
    • Contact
  • Features

    • Transient Antibody Production
    • CHO cells – first choice for antibody production
    • Antibody reformatting and engineering
    • Scalability & Reproducibility

    Antibodies

    • Recombinant Antibodies
    • Afucosylated antibodies
    • Fc-silenced antibodies
    • Bispecific/multispecific antibodies

    Resources

    • Blog
    • Encyclopedia
    • Publications
Contact
  • Expression Services

    Recombinant Ab Production Service

    Afucosylated Ab Service

    Fc-silenced Ab Service

    Bispecific Ab Production Service

    Hight-Throughput Ab Production Service

    Other Protein Production

  • Products
  • Our Technologies

      Our Technologies

      STR – True Fc Silencing Technology

      GlymaxX® – Glycoengineering and ADCC Enhancement

      Opti-mAb® scFv Stabilization

      Our Technologies
  • About us

      About us

      About Evitria

      Events

      Partnerships

      FAQs

      Contact

  • Antibody Journal

      Antibody Journal

      Features

      Transient Antibody Production

      CHO cells – first choice for antibody production

      Antibody reformatting and engineering

      Scalability & Reproducibility

      Antibodies

      Recombinant Antibodies

      Afucosylated antibodies

      Fc-silenced antibodies

      Bispecific/multispecific antibodies

      Resources

      Blog

      Encyclopedia

      Publications

Let’s get in contact
  • LinkedIn
  • YouTube
  1. evitria
  2. tag2

tag2

  • Afucosylated antibodies
  • Antibodies
  • Antibodies Journal
  • Bispecific antibodies
  • CHO Cells
  • High-Throughput
  • Monoclonal antibodies
  • News
  • Recombinant antibodies
  • Therapy Development

  • Bispecific antibodies

    Bispecific Antibodies: A Comprehensive Overview

    BsAbs are a comparatively new and extremely promising class of antibodies. In this article, we provide an overview of bispecific antibodies, including their mechanism of action and expressions.

    Avatar
    Dr. Stefan Schmidt
    March 23, 2026
  • Afucosylated antibodies

    Antibody-Dependent Cellular Cytotoxicity (ADCC) – Definition, Mechanism & Application

    Antibody-dependent cellular cytotoxicity is a key process of the immune system’s arsenal to ward off cancerous cells and infections. We show you important definitions and the ADCC mechanism and key facts on ADCC antibodies in this post.

    Avatar
    Brad Gartland
    September 16, 2025
  • Therapy Development

    Speed vs. Quality in Early Drug Development: Striking the Right Balance for Antibody Therapeutics

    In drug development, speed without reproducibility risks costly setbacks. This article shows how high-quality antibody materials, early testing, and smart design enable faster, more reliable programs without compromising rigor.

    Avatar
    Dr. Stefan Schmidt
    August 14, 2025
  • Therapy Development

    Why Promising Antibody Candidates Fail Before Clinical Trials – and How to Avoid It

    Despite strong market growth, most antibody candidates fail early due to developability, pharmacokinetics, or immunogenicity issues. This article outlines key risks and strategies to de-risk development and speed the path from discovery to IND.

    Avatar
    Dr. Stefan Schmidt
    August 14, 2025
  • Therapy Development

    Fast-Tracking Bispecific Antibody Development: What Can Go Wrong?

    Bispecific antibodies hold great promise, but rushing development can trigger design and manufacturing risks. This article explores how smart strategies and expert partnerships accelerate bsAb programs without compromising quality.

    Avatar
    Dr. Stefan Schmidt
    August 14, 2025
  • Therapy Development

    The Risks of Over-Promising in Early-Stage Biologics Development

    In early biologics development, over-promising can derail programs and erode trust. This article explores the causes, consequences, and how data-driven planning safeguards progress and credibility.

    Avatar
    Dr. Stefan Schmidt
    August 14, 2025
  • CHO Cells

    CHO cells – 7 facts about the cell line derived from the ovary of the Chinese hamster

    Cells derived from animals like Chinese hamster ovary cells have been cultured and manipulated for use in pharmaceutical compounds for decades. They form the vital basis of a vast number of applications and are perfect tools for research and development.

    Avatar
    Brad Gartland
    May 3, 2022
  • Antibodies

    The history of antibodies

    Due to the Corona pandemic, the term “antibody” has become one of the buzzwords of 2020/2021. The history of antibodies, also known as immunoglobulin, of course reaches back far further than the early months of 2020 – their meaning and importance has not only started gaining relevance with the outbreak of COVID-19.

    Avatar
    Team evitria
    January 7, 2021

4 weeks from sequence to recombinant antibody.

  • LinkedIn
  • YouTube
  • Privacy Policy
  • About Evitria
  • HTML Sitemap

©2026 evitria ag

PowerEd by

We Value Your Privacy

This website uses cookies to enhance your browsing experience and provide personalized services. We require your consent to set these cookies on your device. Please note that we also use cookies from US companies that have not signed up to the EU-US data protection agreement.

Your Privacy

This site uses tracking technologies. You may opt in or opt out of the use of these technologies.

Marketing cookies and services are used to deliver personalized advertisements, promotions, and offers. These technologies enable targeted advertising and marketing campaigns by collecting information about users' interests, preferences, and online activities.

Analytics cookies and services are used for collecting statistical information about how visitors interact with website. These technologies provide insights into website usage, visitor behavior, and site performance to understand and improve the site and enhance user experience.

Personalization cookies enable the website to remember your choices and provide enhanced, more personal features. These cookies may track your preferences and show you relevant content based on your browsing patterns.

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features.

Essential cookies are necessary for the website to function properly. These cookies ensure basic functionalities and security features of the website.